molsidomine has been researched along with Cardiac Remodeling, Ventricular in 2 studies
Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Molsidomine was unable to significantly attenuate mortality, development of heart failure and morphological damage induced by DAU." | 5.43 | Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings? ( Adamcová, M; Bureš, J; Hroch, M; Jansová, H; Jirkovská-Vávrová, A; Jirkovský, E; Kovaříková, P; Lenčová-Popelová, O; Mazurová, Y; Pokorná, Z; Reimerová, P; Šimůnek, T; Štěrba, M; Vostatková, L, 2016) |
| "Molsidomine was unable to significantly attenuate mortality, development of heart failure and morphological damage induced by DAU." | 1.43 | Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings? ( Adamcová, M; Bureš, J; Hroch, M; Jansová, H; Jirkovská-Vávrová, A; Jirkovský, E; Kovaříková, P; Lenčová-Popelová, O; Mazurová, Y; Pokorná, Z; Reimerová, P; Šimůnek, T; Štěrba, M; Vostatková, L, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shan, Y | 1 |
| Wang, D | 1 |
| Li, R | 1 |
| Huang, C | 1 |
| Lenčová-Popelová, O | 1 |
| Jansová, H | 1 |
| Jirkovský, E | 1 |
| Bureš, J | 1 |
| Jirkovská-Vávrová, A | 1 |
| Mazurová, Y | 1 |
| Reimerová, P | 1 |
| Vostatková, L | 1 |
| Adamcová, M | 1 |
| Hroch, M | 1 |
| Pokorná, Z | 1 |
| Kovaříková, P | 1 |
| Šimůnek, T | 1 |
| Štěrba, M | 1 |
2 other studies available for molsidomine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Molsidomine Attenuates Ventricular Electrical Remodeling and Arrhythmogenesis in Rats With Chronic β-Adrenergic Receptor Activation Through the NO/cGMP/PKG Pathway.
Topics: Adrenergic beta-Agonists; Animals; Arrhythmias, Cardiac; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dep | 2016 |
Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Cell Line, | 2016 |